首页> 外国专利> PHOSPHORIC ACID REMOVING REAGENT IN CLINICAL INSPECTION LIQUID AND HYDRAULYSIS OF STEROID CONJUGATED TREATED THEREBY

PHOSPHORIC ACID REMOVING REAGENT IN CLINICAL INSPECTION LIQUID AND HYDRAULYSIS OF STEROID CONJUGATED TREATED THEREBY

机译:临床检查液体中的磷酸去除剂及其共轭甾体的水解

摘要

PURPOSE:To elevate the phosphoric acid removing effect in an inspection liquid, by arranging a phosphoric acid removing reagent composed of a first reagent in which MgCl2-NH4Cl and a second reagent of an ammonia solution. CONSTITUTION:A phosphoric acid removing reagent in a clinical inspection liquid is composed of the following first and second reagents: 2.4-3.3g of MgCl2 (5-7g for MgCl2.6H2O) and 10-13g of NH4Cl dissolved in a deioned solution per 50ml thereof and 25-28% of an ammonia solution. 100-300mul of the first reagent and 50-70mul are added to an inspection liquid controlled toward the alkali side from pH6.5 per 1ml thereof and after the agitation thereof, the mixture undergoes centrifugal operation and a conjugated hydrolytic enzyme is acted upon the supernatant. Thus, the use of the reagents produces a high effect of removing phosphoric acid in the inspection liquid while enabling the removal of phosphoric acid in the inspection liquid by a handy processing means.
机译:目的:通过布置由第一试剂(其中MgCl2-NH4Cl和氨溶液的第二试剂)组成的磷酸去除试剂,提高检查液中的磷酸去除效果。组成:临床检查液中的磷酸去除剂由以下第一和第二种试剂组成:每50毫升溶解在去离子溶液中的2.4-3.3克MgCl2(对于MgCl2.6H2O为5-7克)和10-13克NH4Cl它们和25-28%的氨溶液。将100-300mul第一试剂和50-70mul添加到从每1ml pH6.5向碱侧控制的检查液中,并且在搅拌之后,将混合物进行离心操作并且将缀合的水解酶作用于上清液。 。因此,试剂的使用在去除检查液中的磷酸的同时产生高效的效果,同时能够通过方便的处理手段去除检查液中的磷酸。

著录项

  • 公开/公告号JPH054028B2

    专利类型

  • 公开/公告日1993-01-19

    原文格式PDF

  • 申请/专利权人 TOKYO ZOKI KAGAKU KK;

    申请/专利号JP19850142041

  • 发明设计人 TSUKADA TAKAKO;

    申请日1985-06-28

  • 分类号G01N33/48;C12Q1/34;G01N33/74;G01N33/92;

  • 国家 JP

  • 入库时间 2022-08-22 05:20:32

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号